Charing Cross & Hammersmith Hospitals
Charing Cross & Hammersmith Hospitals are part of Imperial College Healthcare NHS Trust, one of the leading cancer centres in the UK
Imperial College Trust is one of the largest NHS trusts in the country, covering five hospitals across central and west London with more than 15,000 staff.
Their cancer service is one of the leading cancer centres in the UK, offering cutting-edge treatments. They have one of the highest clinical trial recruitment rates, which leads to one of the best survival rates in the country.


The Gestational Trophoblastic Disease (GTD) service at Charing Cross Hospital is a highly specialist service providing comprehensive registration, screening and clinical management for all forms of the disease.
The internationally renowned GTD team led by Professor Michael Seckl are world leaders in the investigation and treatment of these rare conditions. Charing Cross Hospital is one of only two hospitals in the UK which treat GTD.
Our Research at Charing Cross & Hammersmith Hospitals
GTD
Led by world renowned GTD specialist Professor Michael Seckl, CTRT is the only charity in the UK fundraising for research into this rare disease which can develop during or after pregnancy
Cancer Immunology & Immunotherapy
The development of immunotherapy in treating various cancer types is an exciting area of cancer research and CTRT is proud to support studies into this therapy across all of our partner hospitals

How You Can Help
We need your support to continue running life-changing clinical trials. From hosting a coffee morning to leaving a gift in your will, there are many ways you can help us find kinder, more effective treatments for patients with cancer.